Hydromer, Inc. (HYDI) Stock
Hydromer, Inc. (HYDI) is a company dedicated to the full lifecycle of hydrophilic polymer-based solutions, from invention and patenting to manufacturing and global sales of both products and services.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Hydromer, Inc.
Hydromer, Inc. (HYDI) is a company dedicated to the full lifecycle of hydrophilic polymer-based solutions, from invention and patenting to manufacturing and global sales of both products and services. Its operations are divided into two primary divisions: Polymer Research and Medical Products. The company's diverse offerings include specialized medical coatings and related services, medical hydrogel formulations, and key ingredients for cosmetic products. Hydromer also develops advanced coatings for condensation control (specifically anti-fog and anti-frost applications), manufactures various cosmetics and personal care items, and provides protective coatings for watercraft hulls. Additionally, it extends its expertise through engineering and contract coating services. Established in 1980 and headquartered in Branchburg, New Jersey, Hydromer serves a broad spectrum of industries, including the medical, cosmetics, animal health, and industrial sectors.
Hydromer, Inc. is headquartered in US.
Hydromer, Inc. (HYDI) stock trades at $0.22 with a market capitalization of $1.05M. The stock is valued at a price-to-earnings (P/E) ratio of -0.65, price-to-book of -7.15, price-to-sales of 0.28. Over the past 52 weeks the stock has ranged between $0.01 and $0.45, and currently trades 51.1% below its 52-week high.
On profitability, Hydromer, Inc. generates a return on equity (ROE) of -244.47%, return on capital employed of -209.39%, an operating margin of -45.56%, a net profit margin of -42.75%.
Official website: www.hydromer.com